EUVIMEDEUVIMED entdecken
Crossref

Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team

Maria Olívia Barboza Zanetti iD, João Paulo Vilela Rodrigues iD, Fabiana Rossi Varallo, Renato Luiz Guerrino Cunha, Belinda Pinto Simões, Leonardo Régis Leira Pereira

Journal of Oncology Pharmacy Practice · 2023-03 · 29 (2) · 375-385

DOI: 10.1177/10781552211073797 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Oncology Pharmacy Practice, online erschienen am 17.01.2022. Verfasst von Maria Olívia Barboza Zanetti und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Graft vs Host Disease. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Brazilian National Council for Scientific and Technological Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Allogeneic Hematopoietic Stem Cells Transplantation (allo-HSCT) is capable of curing patients with neoplastic or non-neoplastic hematologic disorders or of prolonging their survival. This study assessed if the insertion of the clinical pharmacist in the allo-HSCT team modified the outcomes: transplantation-related mortality, grafting failure, incidence of Graft versus Host Disease, hospitalization time, time for grafting, number of readmissions, number of drug-related problems (DRPs), adherence and knowledge about pharmacotherapy.

Methods

Interventional study with historical control carried out in an allo-HSCT unit, in which the intervention group (IG) included 33 individuals who received pharmacotherapy follow-up. Control Group (CG) consisted of 28 individuals.

Results

A total of 250 DRPs were identified, 59 team's doubts were clarified, and 309 interventions were conducted in the IG. The DRPs mainly arose from safety (51.60%) and effectiveness (38.40%) problems. A mean of 9.36 (SD = 6.97) interventions per patient was obtained, mainly including dose reductions (19.09%), adjustments in administration time (18.12%), educational activities (15.21%) and drug removal (10.68%). Clinical significance of the interventions was considered high (75.7% extremely significant, very significant or significant), as well as their acceptability (89.7% accepted). Each patient attended a mean of 4.68 pharmaceutical consultations (SD = 1.91) after hospital discharge, presenting increase in knowledge (p = 0.0001) and in adherence (p = 0.0115). There was no evidence of differences between the groups in the other outcomes analyzed.

Conclusions

The pharmacotherapy follow-up allowed detecting several DRPs and performing interventions of high clinical relevance and acceptability, in addition to improving adherence and individualizing the pharmacotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationGraft vs Host DiseaseHumansPharmacistsHospitalizationHematopoietic Stem CellsRetrospective Studies

Stichwörter der Autor:innen

Pharmaceutical servicesbone marrow transplantationhematopoietic stem cell transplantationmedication therapy management

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil.
  • Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil.

ORCID-Profile: Maria Olívia Barboza Zanetti, João Paulo Vilela Rodrigues

Förderung

  • Brazilian National Council for Scientific and Technological Development

Zitieren

APA

Zanetti, M. O. B., Rodrigues, J. P. V., Varallo, F. R., Cunha, R. L. G., Simões, B. P., & Pereira, L. R. L. (2023). Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team. Journal of Oncology Pharmacy Practice, 29(2), 375-385. https://doi.org/10.1177/10781552211073797

Vancouver

Zanetti MOB, Rodrigues JPV, Varallo FR, Cunha RLG, Simões BP, Pereira LRL. Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team. Journal of Oncology Pharmacy Practice. 2023;29(2):375-385. doi:10.1177/10781552211073797

BibTeX
@article{Zanetti2023,
  author = {Zanetti, Maria Olívia Barboza and Rodrigues, João Paulo Vilela and Varallo, Fabiana Rossi and Cunha, Renato Luiz Guerrino and Simões, Belinda Pinto and Pereira, Leonardo Régis Leira},
  title = {Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team},
  journal = {Journal of Oncology Pharmacy Practice},
  year = {2023},
  volume = {29},
  number = {2},
  pages = {375--385},
  doi = {10.1177/10781552211073797}
}
Kostenlos starten →